methyl 3-Allyl-1-methyl-indole-2-carboxylate | 1620658-63-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: methyl 3-Allyl-1-methyl-indole-2-carboxylate
• CAS: 1620658-63-0
• 化学式: C₁₄H₁₅NO₂
• 分子量: 229.279
• InChiKey: DLGMRCNDMOMAGB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.69
• 重原子数：
  17.0
• 可旋转键数：
  3.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  31.23
• 氢给体数：
  0.0
• 氢受体数：
  3.0

反应信息

• 作为反应物：
  描述：

  methyl 3-Allyl-1-methyl-indole-2-carboxylate 在 lithium hydroxide monohydrate 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 反应 1.0h， 以78%的产率得到3-allyl-1-methylindole-2-carboxylic acid
  参考文献：
  名称：

  Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors

  摘要：

  New series of 2,3,4,5-tetrahydro[1,4]diazepino[1,2-a]indol-1-ones and 3,4,5,10-tetrahydro-2H-diazepino[3,4-b]indol-1-ones have been synthesized through an iodolactonisation/lactone-to-lactam rearrangement sequence. These compounds were evaluated as potential protein kinase inhibitors (CDK1, CDK5 and GSK-3). 11-Iodo-2,3,4,5-tetrahydro[1,4]diazepino[1,2-a]indol-1-one derivatives exhibited sub-micromolar inhibitory activity against cyclin-dependent kinases. Docking studies were realized to determine the binding mode of the inhibitors into the ATP binding domain of the CDK5 catalytic site. Our result highlighted two weak Van-der-Waals bonding interactions established between the iodine atom and both phenyl group of Phe 80 and ammonium end of Lys 33.

  DOI：

  10.1016/j.ejmech.2014.06.063
• 作为产物：
  描述：

  1-tert-butyl 2-ethyl-3-iodo-1H-indole-1,2-dicarboxylate 在 四(三苯基膦)钯 、 sodium hydride 、 sodium hydroxide 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 、 甲苯 、 mineral oil 为溶剂， 反应 25.0h， 生成 methyl 3-Allyl-1-methyl-indole-2-carboxylate
  参考文献：
  名称：

  Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors

  摘要：

  New series of 2,3,4,5-tetrahydro[1,4]diazepino[1,2-a]indol-1-ones and 3,4,5,10-tetrahydro-2H-diazepino[3,4-b]indol-1-ones have been synthesized through an iodolactonisation/lactone-to-lactam rearrangement sequence. These compounds were evaluated as potential protein kinase inhibitors (CDK1, CDK5 and GSK-3). 11-Iodo-2,3,4,5-tetrahydro[1,4]diazepino[1,2-a]indol-1-one derivatives exhibited sub-micromolar inhibitory activity against cyclin-dependent kinases. Docking studies were realized to determine the binding mode of the inhibitors into the ATP binding domain of the CDK5 catalytic site. Our result highlighted two weak Van-der-Waals bonding interactions established between the iodine atom and both phenyl group of Phe 80 and ammonium end of Lys 33.

  DOI：

  10.1016/j.ejmech.2014.06.063

文献信息

• Carboxylate-directed C–H allylation with allyl alcohols or ethers
  作者：Xiao-Qiang Hu、Zhiyong Hu、A. Stefania Trita、Guodong Zhang、Lukas J. Gooßen

  DOI：10.1039/c8sc01741g

  日期：——

  A [Ru(p-cymene)Cl2]2 catalyst activates allyl alcohols and ethers for the regioselective ortho-C–H allylation of aromatic and heteroaromatic carboxylates. The reaction is orthogonal to most C–H functionalisations with allyl alcohols in that allyl arenes rather than carbonyl compounds are obtained. A wide range of substrates are thus smoothly transformed to allylarenes at 50 °C in phosphate-buffered

  [Ru（p- Cymene）Cl 2 ] 2催化剂可活化烯丙醇和醚，用于芳族和杂芳族羧酸酯的区域选择性邻位-C-H烯丙基化。该反应与用烯丙醇进行的大多数C–H官能化正交，因为可得到烯丙基芳烃而不是羰基化合物。因此，在磷酸盐缓冲的2,2,2-三氯乙醇中，各种各样的底物可在50°C的条件下平稳转化为烯丙基芳烃。反应概念结合了丰富的试剂和导向基团的使用，以一种可持续的，废物最少的方法形成C-C键。
• Manganese(I) Catalyzed ortho C–H Allylation of Benzoic Acids
  作者：Jonas Felix Goebel、Johanna Stemmer、Florian Belitz、Lukas J Goossen

  DOI：10.1002/anie.202301839

  日期：——

  A simple manganese catalyst sets new standards in the ortho-C−H allylation of benzoates, by allowing nearly complete selectivity for mono- over competing di-allylation. The reaction can be combined with an in situ decarboxylation, giving access to allylarenes in substitution patterns that are otherwise hard to obtain. The scope of the protocol is demonstrated by 44 diverse examples.

  一种简单的锰催化剂为苯甲酸酯的邻位-C−H 烯丙基化设定了新的标准，它允许对单一竞争性双烯丙基化几乎完全选择性。该反应可以与原位脱羧相结合，从而以其他方式难以获得的取代模式获得烯丙基芳烃。该协议的范围由 44 个不同的例子展示。